Title of article :
Strain Selection and Statistical Optimization of Culture Conditions for 19F Polysaccharide Production from Pneumococcus
Author/Authors :
Tarahomjoo, Shirin Division of Genomics and Genetic Engineering - Department of Biotechnology and Central Laboratory - Razi Vaccine and Serum Research Institute - Agricultural Research - Education and Extension Organization (AREEO), Karaj , Refiei Tabatabaei, Sedigheh Pediatric Infections Research Center - Research Institute for Children Health - Mofid Children Hospital - Shahid Beheshti University of Medical Sciences, Tehran , Karimi, Abdollah Pediatric Infections Research Center - Research Institute for Children Health - Mofid Children Hospital - Shahid Beheshti University of Medical Sciences, Tehran , Rahbar, Mohammad Department of Microbiology - Milad Hospital, Tehran
Abstract :
Introduction: Capsular polysaccharides of pneumococci are principle
antigenic constituents of vaccines against pneumococci. Enhancing the yield of
capsule production decreases costs of these vaccines and increases the vaccine
coverage in developing countries. This study aims to optimize the capsule
production from serotype 19F pneumococcus in terms of the applied
pneumococcal strain and environmental culture conditions.
Materials and Methods: Thirteen serotype 19F Streptococcus pneumoniae
strains were screened for the capsule production in modified Hoeprich culture
medium using the stains all assay. The optimal ranges of environmental culture
conditions for the selected strain were determined using single factor at a time
(SFAT) strategy and utilized for the design of experiments based on the
response surface methodology (RSM).
Results: S. pneumoniae 82218 showed the highest capsule production, and
thus used for further studies. The maximum capsule production (1.364 mg/ml)
was attained under optimal conditions (pH 7.26, 35.5 ºC, 30 rpm) predicted by
the RSM derived quadratic model. The capsule production under the optimal
conditions increased to 1.9 mg/ml using the buffered culture medium.
Conclusion: These results are much higher than those reported for
pneumococcal capsule production in published studies [1, 2] and thus can be
used to design suitable systems for the serotype 19F capsule production in the
vaccine manufacturing process.
Keywords :
Models , Pneumococcal vaccines , Polysaccharides , Serogroup , Streptococcus pneumoniae
Journal title :
Archives of Advances in Biosciences